| Recruiting | CD19-targeted CAR T Cells for Relapsed or Refractory (R/R) Large B-cell Lymphoma Non-Hodgkin Lymphoma, Large B-cell Lymphoma | Phase 2 | 2024-08-15 |
| Not Yet Recruiting | Relma-cel for Moderate to Severe Active Systemic Lupus Erythematosus Systemic Lupus Erythematosus | Phase 1 | 2024-03-01 |
| Not Yet Recruiting | Relmacabtagene Autoleucel in Hematologic Malignancies Lymphoma, B-Cell, Large B-cell Lymphoma, Follicular Lymphoma | — | 2023-12-28 |
| Active Not Recruiting | Relmacabtagene Autoleucel As Second-Line Therapy in Adult Patients with Aggressive B-cell NHL Lymphoma, Large B-Cell, Diffuse, Follicular Lymphoma Grade 3B, High-grade B-cell Lymphoma | Phase 2 | 2023-11-03 |
| Unknown | CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Large B-cell Lymphoma Lymphoma, Non-Hodgkin, Diffuse Large B Cell Lymphoma | Phase 2 | 2023-08-17 |
| Unknown | CD19-CART(Relma-cel) for Moderate to Severe Active Systemic Lupus Erythematosus Systemic Lupus Erythematosus | Phase 1 | 2023-02-24 |
| Unknown | Relmacabtagene Autoleucel in Patients With LBCL Large B-cell Lymphoma | — | 2022-12-28 |
| Unknown | CD19-targeted CAR T Cells for Patients With Relapsed or Refractory in B-cell Acute Lymphoblastic Leukemia Acute Lymphocytic Leukemia | Phase 1 | 2022-04-28 |
| Unknown | A Phase 1, Single-arm, Open-label, Dose-escalation Study of JWATM204 as T Cell-targeted Immunotherapy in the T Liver Carcinoma, Hepatic Cell Carcinoma | Phase 1 | 2022-03-24 |
| Withdrawn | Phase I Study of JWCAR029 in Subjects With R/R CLL/SLL Leukemia, Lymphocytic, Chronic, B-Cell | Phase 1 | 2022-02-28 |
| Active Not Recruiting | CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Mantle Cell Lymphoma Mantle Cell Lymphoma | Phase 2 | 2021-01-13 |
| Completed | CD19-targeted CAR T Cells （JWCAR029） for Primary Refractory Diffuse Large B Cell Lymphoma Diffuse Large B Cell Lymphoma | Phase 1 | 2020-07-10 |
| Unknown | CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Non-Hodgkins Lymphoma Lymphoma, Non-Hodgkin, Diffuse Large B Cell Lymphoma, Follicular Lymphoma | Phase 2 | 2019-06-11 |